SPRINGWORKS THERAPEUTICS INC's ticker is SWTX and the CUSIP is 85205L107. A total of 144 filers reported holding SPRINGWORKS THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.74 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $29,784,409 | -5.9% | 1,288,253 | +6.7% | 0.06% | -3.2% |
| Q2 2023 | $31,664,321 | +567.4% | 1,207,640 | +555.1% | 0.06% | +520.0% |
| Q1 2023 | $4,744,759 | -88.1% | 184,334 | -73.8% | 0.01% | -86.7% |
| Q1 2022 | $39,768,000 | +57.4% | 704,597 | +72.9% | 0.08% | +59.6% |
| Q4 2021 | $25,258,000 | +1806.3% | 407,519 | +1850.5% | 0.05% | +683.3% |
| Q3 2021 | $1,325,000 | -72.3% | 20,893 | -67.9% | 0.01% | -72.7% |
| Q1 2021 | $4,785,000 | – | 65,044 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 5,831,307 | $480,558,000 | 31.49% |
| Consonance Capital Management LP | 1,199,339 | $98,838,000 | 11.90% |
| Boxer Capital, LLC | 2,075,905 | $171,075,000 | 6.04% |
| Perceptive Advisors | 9,699,824 | $799,362,000 | 5.19% |
| Orbimed Advisors | 6,044,266 | $498,108,000 | 5.04% |
| Samsara BioCapital, LLC | 169,852 | $13,998,000 | 1.73% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 1,375,775 | $113,378,000 | 1.50% |
| SPHERA FUNDS MANAGEMENT LTD. | 195,117 | $16,080,000 | 1.09% |
| Artal Group S.A. | 500,000 | $41,205,000 | 0.84% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 558,574 | $46,032,000 | 0.82% |